Anosmia market seen reaching $6.07B by 2030

The Business Research Company says the global anosmia market is set to rise from $3.86 billion in 2025 to $4.23 billion in 2026, then climb to $6.07 billion by 2030. The report points to neurological disorders, post-infectious care, and treatment advances as key growth drivers, with North America leading and Asia-Pacific expected to grow fastest.

Why it matters: - Anosmia, or loss of smell, can affect taste perception and daily quality of life. - The market is expanding as more patients seek diagnosis and treatment for smell disorders. - Growth in neurological disease, including Alzheimer’s, is increasing demand for anosmia-related care.

What happened: - The Business Research Company released its 2026 anosmia market report covering market size, trends, segment details, and business approaches through 2035. - The report says the global anosmia market will grow from $3.86 billion in 2025 to $4.23 billion in 2026. - The report forecasts the market will reach $6.07 billion by 2030. - The company also published a free sample report and a full report online: Download the sample report and View the full market report.

The details: - The report puts the market’s 2025-2026 CAGR at 9.4%. - The report projects a 9.5% CAGR from 2026 to 2030. - Historical growth is linked to more viral-induced anosmia cases, greater awareness of olfactory disorders, wider access to diagnostic technology, expansion in ENT specialty care, and more reporting of sensory loss. - Forecast growth is tied to olfactory nerve regeneration research, wider use of innovative treatments, growth in post-infectious care programs, demand for therapies that improve quality of life, and more clinical trial activity. - Anosmia is defined as partial or total loss of smell and can be temporary or permanent. - Causes include nasal congestion, nasal polyps, neurological disorders, head injuries, viral infections, and exposure to certain chemicals or medications. - The condition can affect one or both nostrils. - Because smell supports taste, anosmia can reduce enjoyment of food and beverages. - Neurological disorders can damage the olfactory nerves or brain regions that process smell signals. - The Alzheimer’s Association said in March 2023 that about 6.7 million Americans age 65 and older were living with Alzheimer’s dementia, with the number projected to reach 13.8 million by 2060. - In 2025, North America held the largest share of the global anosmia market. - Asia-Pacific is expected to be the fastest-growing region. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. - The report’s expanded capabilities include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, future trend analysis, and updated graphics and tables.

Between the lines: - The report frames anosmia as a niche market with broad overlap across neurology, ENT care, diagnostics, and post-infectious recovery. - The Alzheimer’s data underscores how aging populations can expand the patient pool for smell-loss treatment and testing. - North America’s lead suggests a more mature care ecosystem, while Asia-Pacific’s growth outlook points to rising diagnosis and spending capacity.

What's next: - The market’s next phase likely depends on whether olfactory regeneration research and treatment innovation translate into routine clinical use. - Growth in clinical trials could broaden the pipeline of therapies and diagnostic tools. - Regional gains outside North America will likely hinge on healthcare investment and access to specialty care.

The bottom line: - The anosmia market is moving from a relatively specialized care segment toward a larger global opportunity, with growth supported by neurological disease, post-infectious treatment needs, and new research activity.